Starling Oncology, Inc. Common Stock
NYSE · STLN
Fundamentals
Market cap
$652.26M
Price / Earnings ratio
-10.8x
Price / Sales ratio
0.9x
Price / Book ratio
-20.2x
Return on assets
-0.3%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A


